Benlysta

CRO

Aurinia taps Worldwide Clinical Trials to test lupus candidate in phase 3

After posting positive phase 2b data on its lupus nephritis med voclosporin, Aurinia selected Worldwide Clinical Trials as the CRO to conduct the last round of trials before a new drug application.

Angus Liu Jan 30, 2017 11:07am